Core Viewpoint - The company's 1H25 performance met expectations, with revenue of 1.34 billion RMB, a year-on-year increase of 7.2%, and a net profit of 170 million RMB, a year-on-year decrease of 3.3% [1] Revenue Performance - Revenue from the pet segment doubled, while home care revenue grew steadily, with specific contributions: - Home care product revenue increased by 4.3% to 1.21 billion RMB, driven by strong growth in mosquito repellent new products - Pet and pet product revenue surged by 101.4% to 96 million RMB, with offline stores expanding to 77 and rapid growth in proprietary brand scale - Personal care product revenue decreased by 25.8% to 26 million RMB - Online revenue grew by 27.4% to 520 million RMB, accounting for 38.6% of total revenue, an increase of 6.1 percentage points [1][2] - Offline revenue declined by 2.6% to 820 million RMB, supported by brand reputation and a strong distribution network [1] Gross Margin Improvement - The company's gross margin improved by 2.9 percentage points to 49.3%, driven by: - Upgraded product offerings, with home care and pet product gross margins increasing by 2.7 percentage points and 8.6 percentage points to 49.1% and 58.1%, respectively - Increased online resource investment and optimized e-commerce product structure, with online gross margin rising by 5.5 percentage points to 59.9% - Enhanced supply chain efficiency contributing to margin improvement [2] Strategic Growth Areas - The company is focusing on high-end product upgrades in home care and personal care, with new natural home care products expected to support future growth - The pet business is well-positioned to benefit from the expansion of China's pet industry and the rise of domestic brands, with ongoing store expansion and improved service range expected to drive revenue growth [3] - The company has a strong cash position, with net cash of 2.65 billion RMB as of June 30, and a high dividend payout ratio, indicating substantial shareholder returns [3] Profit Forecast and Valuation - The profit forecast remains unchanged, with the current stock price corresponding to 14/13 times P/E for 2025/26 - The company maintains an outperform rating and a target price of 3.65 HKD, implying a 46% upside potential based on 20/19 times P/E for 2025/26 [3]